SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-19-010506
Filing Date
2019-05-20
Accepted
2019-05-20 16:47:39
Documents
56
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q wint20190331_10q.htm 10-Q 619260
2 EXHIBIT 31.1 ex_145163.htm EX-31.1 8674
3 EXHIBIT 31.2 ex_145164.htm EX-31.2 8684
4 EXHIBIT 32.1 ex_145165.htm EX-32.1 5683
  Complete submission text file 0001437749-19-010506.txt   3510023

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT wint-20190331.xml EX-101.INS 602041
6 XBRL TAXONOMY EXTENSION SCHEMA wint-20190331.xsd EX-101.SCH 42151
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE wint-20190331_cal.xml EX-101.CAL 34683
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wint-20190331_def.xml EX-101.DEF 301514
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE wint-20190331_lab.xml EX-101.LAB 274117
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wint-20190331_pre.xml EX-101.PRE 321259
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Filer) CIK: 0000946486 (see all company filings)

IRS No.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26422 | Film No.: 19839417
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1